Summary
Experts emphasize that India's pharmaceutical sector needs to prioritize innovation and advanced manufacturing over mere cost competitiveness to achieve significant growth. Increased investment in research and digital technologies could boost the market to USD 130 billion by 2030, requiring companies to enhance quality and meet global regulatory standards.